As of Nov 17
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 0.61, with a high estimate of 0.61 and a low estimate of 0.61. The median estimate represents a +3,197.30% increase from the last price of 0.02.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.